Skip to main content
PMC home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1992 Jan;35(1):19–26. doi: 10.1007/BF01741050

Studies of a tumor-associated antigen, COX-1, recognized by a monoclonal antibody

Chi-Yu Gregory Lee 1,✉, Kuang-Wei Chen 1, Fong-Syong Sheu 1, Angus Tsang 1, Kuang-Chong Chao 3, Heung-Tat Ng 3
PMCID: PMC11038318  PMID: 1611619

Abstract

Monoclonal antibodies against an ovarian tumor cell line, OC-3-VGH, were generated using modified hybridoma technology. Among the seven that were selected for their high specificity and affinity to ovarian cancer cells and low cross-reactivity to most normal human tissues, RP 215 was shown to react specifically with a tumor-associated antigen, COX-1, from certain ovarian/cervical cancer cell lines. By Western blot assay, COX-1 was shown to have a subunit molecular mass of about 60 kDa and exist as an aggregate in the native state. COX-1 could also be detected in the shed medium of certain cultured tumor cells. A solid-phase sandwich enzyme-immunoassay procedure was designed for quantitative determinations of COX-1 in the shed medium or in patients' sera using RP 215 for both well-coating and the signal detection. Highly purified COX-1 was obtained from the shed medium of cultured OC-3-VGH tumor cells mainly by hydroxyapatite and immunoaffinity chromatography with RP 215 as the affinity ligand. At neutral pH, purified COX-1 also exists as an aggregate and is relatively stable at temperatures below 50°C. Its immunoactivity was found to decrease with time in the presence of trypsin. However, the immunoactivity of COX-1 was not affected upon incubation with carbohydrate-digestive enzymes or concanavalin A and only partially inactivated in the presence of NaIO4 or iodoacetamide. Treatments of COX-1 with dithiothreitol and guanidine thiocyanate resulted in a complete loss of activity. Furthermore, rabbit antisera raised against purified COX-1 exhibited similar immunospecificity to that of RP 215. The results of this study suggest that COX-1 is a glycoprotein consisting of a 60 kDa subunit, which is recognized by RP 215 through its peptide determinant. Preliminary retrospective clinical studies were performed to assess the utility of a COX-1 enzyme immunoassay kit for detection and monitoring of patients with ovarian and cervical cancers.

Key words: Ovarian/cervical cancers, Monoclonal antibodies, Tumor-associated antigens

References

  • 1.Accolla RS, Carrel S, Mach JP. Monoclonal antibodies specific for carcinoembryonic antigen and produced by two hybrid cell lines. Proc Natl Acad Sci USA. 1980;77:563. doi: 10.1073/pnas.77.1.563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Alvarez RD, To A, Boots LR, Shingleton HM, Hatch KD, Hubbard J, Soong SJ, Potter ME. CA 125 as a serum marker for poor prognosis in ovarian malignancies. Gynecol Oncol. 1987;26:284. doi: 10.1016/0090-8258(87)90019-9. [DOI] [PubMed] [Google Scholar]
  • 3.Atack DB, Nisker JA, Allen HH, Tustanoff ER, Levin L. CA 125 surveillance and second-look laparotomy in ovarian carcinoma. Am J Obstet Gynecol. 1986;154:287. doi: 10.1016/0002-9378(86)90657-5. [DOI] [PubMed] [Google Scholar]
  • 4.Bara J, Malarewicz A, Loisillier F, Burtin P. Antigens common to human ovarian mucinous cyst fluid and gastric mucosa. Br J Cancer. 1977;36:49. doi: 10.1038/bjc.1977.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bast RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68:1331. doi: 10.1172/JCI110380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bast RC, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR, Knapp RCA. Radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983;309:169. doi: 10.1056/NEJM198310133091503. [DOI] [PubMed] [Google Scholar]
  • 7.Bast RC, Klug TL, Schaetzl E, Lavin P, Niloff JM, Greber TF, Zurawski VR, Knapp RC. Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9 and carcinoembryonic antigen. Am J Obstet Gynecol. 1984;149:553. doi: 10.1016/0002-9378(84)90035-8. [DOI] [PubMed] [Google Scholar]
  • 8.Bhattacharya M, Barlow JJ. Ovarian tumor antigens. Cancer. 1978;42:1616. doi: 10.1002/1097-0142(197809)42:3+<1616::aid-cncr2820420840>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  • 9.Bhattacharya M, Barlow JJ. Ovarian cystadenocarcinoma-associated antigen (OCAA) In: Herberman, editor. Compendium of assay for immunodiagnosis of human cancer. Amsterdam: Elsevier-North Holland; 1979. p. 431. [Google Scholar]
  • 10.Bhattacharya M, ChatterJee SK. Antigen markers in ovarian cancer. Proc Am Assoc Cancer Res. 1980;21:216. [Google Scholar]
  • 11.Bhattacharya M, ChatterJee SK, Barlow JJ, Fuji H. Monoclonal antibodies recognizing tumor associated antigens of human ovarian mucinous cystadenocarcinoma. Cancer Res. 1982;42:1650. [PubMed] [Google Scholar]
  • 12.Chao KC, Ng HT, Chang CC. Characteristics of a newly established ovarian carcinoma cell lines, OC-3-VGH. Chin Med J [Engl] 1982;39:147. [PubMed] [Google Scholar]
  • 13.Chow SN, Ho-Yuen B, Lee CYG. Application of monoconal antibodies in immunoassays of human luteinizing hormone. J Appl Biochem. 1985;7:114. [PubMed] [Google Scholar]
  • 14.Davis JM, Pennington JE, Kubler AM, Conscisnce JF. A simple, single-step technique for selecting and cloning hybridomas for the production of monoclonal antibodies. J Immunol Methods. 1982;50:161. doi: 10.1016/0022-1759(82)90222-8. [DOI] [PubMed] [Google Scholar]
  • 15.Disaia PJ, Creasman WT. Advanced epithelial ovarian cancer. In: Disaia PJ, Creasman WT, editors. Clinical gynaecologic onoclogy. St. Louis, Mo.: Mosby; 1981. p. 253. [Google Scholar]
  • 16.Donaldson ES, Nagell JRV, Pursell S, Gay EC, Meeker WR, Mashmiri R, Voorde JVD. Multiple biochemical markers in patients with gynecologic malignancies. Cancer. 1980;45:948. doi: 10.1002/1097-0142(19800301)45:5<948::aid-cncr2820450519>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  • 17.Finkler NJ, Knapp RC, Bast RC. Monoclonal antibodies in ovarian cancer. In: Kupchik HZ, editor. Cancer diagnosis in vitro using monoclonal antibodies, chapter 6. New York: Dekker; 1988. p. 141. [Google Scholar]
  • 18.Fleuren GJ, Coerkamp EG, Nap M, van der Broek LJCM, Warnaar SO. Immunohistological characterization of a monoclonal antibody (OV 632) against epithelial ovarian carcinoma. Virchows Arch [A] 1987;410:481. doi: 10.1007/BF00781682. [DOI] [PubMed] [Google Scholar]
  • 19.Greenwood FC, Hunter WN. The preparation of I131-labeled human growth hormone of high specific radioactivity. Biochem J. 1963;89:114. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Heyningen VV. A Simple method for ranking the affinities of monoclonal antibodies. Methods Enzymol. 1986;121:472. doi: 10.1016/0076-6879(86)21046-0. [DOI] [PubMed] [Google Scholar]
  • 21.Hsu SM, Raine L, Fanger H. Use of an avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem. 1981;29:577. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  • 22.Imamura N, Takahashi T, Lloyd KO, Lewis JL, Old LJ. Analysis of human ovarian tumor antigens using heterologous antisera. Detection of new antigenic systems. Int J Cancer. 1978;21:570. doi: 10.1002/ijc.2910210506. [DOI] [PubMed] [Google Scholar]
  • 23.Introna M, Bast RC. Epithelial ovarian carcinoma: cell lines and antigenic tumor markers. In: Williams CJ, Whitehouse JMA, editors. Cancer of female reproductive system, vol 1. Chichester, UK: Wiley; 1985. p. 153. [Google Scholar]
  • 24.Jacobs I, Bast RC. The CA 125 tumor-associated antigen: a review of the literature. Human Reprod. 1989;4:1. doi: 10.1093/oxfordjournals.humrep.a136832. [DOI] [PubMed] [Google Scholar]
  • 25.Kabawat SE, Bast RC, Bhan AK, Welch WR, Knapp RC, Colvin RB. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC 125. Int J Gynecol Pathol. 1983;2:275. doi: 10.1097/00004347-198303000-00005. [DOI] [PubMed] [Google Scholar]
  • 26.Kabawat SE, Bast RC, Welch WR, Knapp RC, Colvin RB. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometroid, and clear cell types. Am J Clin Pathol. 1983;79:98. doi: 10.1093/ajcp/79.1.98. [DOI] [PubMed] [Google Scholar]
  • 27.Kawahara M, Terasaki PI, Chia D, Johnson C, Hermes M, Tokita K. Use of four monoclonal antibodies to detect tumor markers. Cancer. 1986;58:2008. doi: 10.1002/1097-0142(19861101)58:9<2008::aid-cncr2820580909>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  • 28.Knauf S, Bast RC. Tumor antigen NB/70K and CA 125 levels in the blood of preoperative ovarian cancer patients and Controls: a preliminary report of the use of the NB12 123 and CA 125 radioimmunoassays alone and in combination. Int J Biol Markers. 1988;3:75. doi: 10.1177/172460088800300201. [DOI] [PubMed] [Google Scholar]
  • 29.Knauf S, Urbach CI. The development of a double antibody radioimmunoassay for detecting ovarian tumor associated antigen fraction OCA in plasma. Am J Obstet Gynecol. 1978;131:780. doi: 10.1016/0002-9378(78)90247-8. [DOI] [PubMed] [Google Scholar]
  • 30.Knauf S, Urbach GI. A study of ovarian cancer patients using a radioimmunoassay for human ovarian tumor-associated antigen OCA. Am J Obstet Gynecol. 1980;138:1222. doi: 10.1016/s0002-9378(16)32797-1. [DOI] [PubMed] [Google Scholar]
  • 31.Knauf S, Urbach GI. Identification, Purification, and radioimmunoassay of NB/70K, a human ovarian tumor-associated antigen. Cancer Res. 1981;41:1351. [PubMed] [Google Scholar]
  • 32.Knauf S, Anderson DJ, Knapp RC, Bast RC. Study of the NB/70K and CA 125 monoclonal antibody radioimmunoassay for measuring serum antigen levels in ovarian cancer patients. Am J Obstet Gynecol. 1985;152:911. doi: 10.1016/s0002-9378(85)80091-0. [DOI] [PubMed] [Google Scholar]
  • 33.Kurman RJ, Scardino PT, McIntire KR, Waldman TA, Javadpour N, Norris HJ. Malignant germ cell tumor of the ovary and testis. An immunological study of 69 cases. Ann Clin Lab Sci. 1979;9:462. [PubMed] [Google Scholar]
  • 34.Lee CYG, Huang YS, Hu PC, gomel V, Menge AC. Analysis of sperm antigens by sodium dodecyl sulfate gel/protein blot radioimmunobinding method. Anal Biochem. 1982;123:14. doi: 10.1016/0003-2697(82)90617-0. [DOI] [PubMed] [Google Scholar]
  • 35.Lee CYG, Wong E, Teh CZ. Analysis of a sperm isoantigen using monoclonal antibodies. Am J Reprod Immunol. 1984;6:27. doi: 10.1111/j.1600-0897.1984.tb00107.x. [DOI] [PubMed] [Google Scholar]
  • 36.Magnani JL, Steplewski Z, Koprowski H, Ginsburg V. Identification of the gastrointestinal and pancreatic cancer associated antigen detected by monoclonal antibody 19-9 in the sera of patient as mucin cancer. Cancer Res. 1983;43:5485. [PubMed] [Google Scholar]
  • 37.Mainguene C, Aillet G, Kremer M, Chatal JF. Immunohistochemical study of ovarian tumors using the OC 125 monoclonal antibody as a basis for potential in vivo and in vitro applications. J Nucl Med. 1986;30:19. [PubMed] [Google Scholar]
  • 38.Masuho Y, Salutsky M, Knapp RC, Bast RC (1984) Interaction of monoclonal antibodies with cell surface antigens of human ovarian carcinoma 44: 2813 [PubMed]
  • 39.Miotti S, Aguanno S, Canevari S, Diotti A, Orlandi R, Sonnino S, Colnaghi MI. Biochemical analysis of ovarian cancer-associated antigens defined by murine monoclonal antibodies. Cancer Res. 1989;45:826. [PubMed] [Google Scholar]
  • 40.Novak ER, Jones GS, Jones HW. Ovarian cyst and tumors. In: Novak ER, Jones GS, Jones HW, editors. Novak's textbook of gynaecology, chapter 32. Baltimore, Md: Williams and Wilkins; 1989. p. 783. [Google Scholar]
  • 41.Ouchterlony O. Double immunodiffusion in gel. Prog Allergy. 1958;5:1. [PubMed] [Google Scholar]
  • 42.Podczaski E, Whitney C, Manetta A, Larson JE, Kirk J, Stevens CW, Lyter J, Mortel R. Use of CA 125 to monitor patients with ovarian epithelial carcinomas. Gynecol Oncol. 1989;33:193. doi: 10.1016/0090-8258(89)90550-7. [DOI] [PubMed] [Google Scholar]
  • 43.Stahl P, Six H, Rodman JS, Schlesinger P, Tulsiani DRP, Touster O. Evidence for specific recognition sites mediating clearance of lysosomal enzymes in vivo. Proc Natl Acad Sci USA. 1976;73:4045. doi: 10.1073/pnas.73.11.4045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Stall KE, Martin EW. Plasma carcinoembryonic antigen levels in ovarian cancer patients. J Reprod Med. 1981;26:73. [PubMed] [Google Scholar]
  • 45.Tagliabue E, Menard S, Torro GD, Barbanti P, Mariani-Costantini R, Porro G, Colnaghi MI. Generation of monoclonal antibodies reacting with human epithelial ovarian cancer. Cancer Res. 1985;45:379. [PubMed] [Google Scholar]
  • 46.Talerman A, Haije WG, Baggerman L. Serum alpha-feto-protein (AFP) in diagnosis and management of endodermal sinus (yolk sac) tumor and mixed germ cell tumor of the ovary. Cancer. 1978;41:272. doi: 10.1002/1097-0142(197801)41:1<272::aid-cncr2820410138>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  • 47.Thor A, Muraro R, Gorstein F, Ohuchi N, Viglione M, Szpak CA, Johnston WW, Schlom J. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity. Cancer Res. 1987;47:505. [PubMed] [Google Scholar]
  • 48.Tsuji Y, Suzuki T, Nishiura H, Takemura T, Isojima S. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies. Cancer Res. 1985;45:2358. [PubMed] [Google Scholar]
  • 49.Ward BG, Cruickshank DJ. Circulating tumor-associated antigen detected by the monoclonal antibody HMFG2 in human epithelial ovarian cancer. Int J Cancer. 1987;39:30. doi: 10.1002/ijc.2910390107. [DOI] [PubMed] [Google Scholar]
  • 50.Ward BG, Cruickshank DJ, Tucker DF, Love S. Independent expression in serum of three tumor associated antigens: CA 125, placental alkaline phosphatase and HMFG 2 in ovarian carcinoma. Br J Obstet Gynecol. 1987;94:696. doi: 10.1111/j.1471-0528.1987.tb03178.x. [DOI] [PubMed] [Google Scholar]
  • 51.Wu JT. Expression of monoclonal antibody-defined tumor markers in four carcinomas. Ann Clin Lab Sci. 1989;19:17. [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES